Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Overview of attention for article published in Journal of Clinical Oncology, November 2005

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 review on a research highlight platform.

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.